List view / Grid view

Viking Therapeutics

 

news

Viking announces new preclinical results for VK5211

8 December 2015 | By Victoria White

VK5211 is an orally available, non-steroidal selective androgen receptor modulator (SARM) designed to selectively stimulate muscle and bone formation with reduced activity in peripheral tissues such as skin and prostate...